Mice transgenic for cyclin D1 are prone to tumour development, the type of tumour being dependent on the enhancer sequence used to construct the cyclin D1 transgene (Bodrug et al, 1994; Wang et al, 1994; Robles et al, 1996). This evidence concerns the gene CCND1 and neoplasm.